NEW YORK (360Dx) – Unilabs this week announced the offering of €130 million ($152.9 million) aggregate principal amount of its existing 5.75 percent senior notes due 2025.
Proceeds from the offering will go toward financing, in part, acquisitions by Unilabs during the past few months, including the buys of Base Holding, CGC, Blufstein, Scientific Clinical Laboratories, and other recently acquired companies, it said. The Swiss firm added that proceeds will also be used to pay certain fees and expenses associated with the transactions.